105 related articles for article (PubMed ID: 6536099)
1. [HBcAb-IgM/HBcAb-IgG in the course of virus B infections: features of importance for the diagnosis, prognosis and pathogenetic interpretations].
Bedarida G; Cambie' G; D'Agostino F; Cargnel A; Sterza G; Bolzoni M; Lo Cicero F; Grisi ME; Ronsivalle MG
Riv Emoter Immunoematol; 1984; 31(2):195-223. PubMed ID: 6536099
[No Abstract] [Full Text] [Related]
2. [Importance of the immune system in the symptom-free HBsAg carrier state].
Mansurov KhKh; Asfandiiarova NS
Klin Med (Mosk); 1984 Jun; 62(6):17-21. PubMed ID: 6381874
[No Abstract] [Full Text] [Related]
3. Limitations of solid-phase radioimmunoassay for hb ag in reducing frequency of post-transfusion hepatitis.
Hollinger FB; Aach RD; Gitnick GL; Roche JK; Melnick JL
N Engl J Med; 1973 Aug; 289(8):385-91. PubMed ID: 4719826
[No Abstract] [Full Text] [Related]
4. Viral markers of hepatitis.
Velasco M
Lab Res Methods Biol Med; 1983; 7():103-17. PubMed ID: 6413796
[No Abstract] [Full Text] [Related]
5. [Virus antibodies and the infectiousness of serum in hepatitis B].
Niermeijer P; Gips CH
Ned Tijdschr Geneeskd; 1979 Apr; 123(17):716. PubMed ID: 375104
[No Abstract] [Full Text] [Related]
6. [The use of a test for anti-HBc for prevention of post-transfusion hepatitis B].
Somova AV; Margolina AN; Golosova TV; Fisenko EP; Tsibinogin VV; Loseva VIa
Vopr Virusol; 1989; 34(6):749-52. PubMed ID: 2633470
[No Abstract] [Full Text] [Related]
7. [Currently available means for the prevention of post-transfusion hepatitis and criteria for their application].
Bedarida G; Cambiè G; D'Agostino F; Sterza G
Ric Clin Lab; 1984; 14 Suppl 1():37-60. PubMed ID: 6429830
[No Abstract] [Full Text] [Related]
8. [Value of IgM and IgG class anti-HBs in the differential diagnosis of viral hepatitis B and "non-A, non-B"].
Bugaeva NP; Mikhaĭlov MI; Favorov MO; Ketiladze ES
Vopr Virusol; 1981; (5):621-4. PubMed ID: 6801859
[No Abstract] [Full Text] [Related]
9. [Immunoenzyme analysis for determining class G and M antibodies to HBsAg].
Sokolenko AA; Slavin MN; Shakhanina KL
Zh Mikrobiol Epidemiol Immunobiol; 1988 Feb; (2):99-103. PubMed ID: 3129891
[TBL] [Abstract][Full Text] [Related]
10. [Study on the immunoglobulin class of the antibody anti-e in acute HBsAg+ hepatitis and in asymptomatic carriers of HBsAg (author's transl)].
Federico G; Pizzigallo E; Nervo P
Ann Sclavo; 1979; 21(1):20-4. PubMed ID: 485588
[TBL] [Abstract][Full Text] [Related]
11. Humoral immune response in Hepatitis B virus infections.
Vranckx R
Infection; 1983; 11(2):114-7. PubMed ID: 6862635
[No Abstract] [Full Text] [Related]
12. Anti-hepatitis B core immunoglobulin M in the serologic evaluation of hepatitis B virus infection and simultaneous infection with type B, delta agent, and non-A, non-B viruses.
Perrillo RP; Chau KH; Overby LR; Decker RH
Gastroenterology; 1983 Jul; 85(1):163-7. PubMed ID: 6406288
[TBL] [Abstract][Full Text] [Related]
13. What you need to know: interpreting hepatitis B viral markers.
Tan CK
Singapore Med J; 1998 Mar; 39(3):139-40. PubMed ID: 9632977
[No Abstract] [Full Text] [Related]
14. Experimental transmission of the delta virus to a hepatitis B chronic carrier chimpanzee with the development of persistent delta carriage.
Fields HA; Govindarajan S; Margolis HS; Schable CD; Ebert JW; Maynard JE
Am J Pathol; 1986 Feb; 122(2):308-14. PubMed ID: 3511725
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic and prognostic significance of the IgM antibody to the hepatitis delta virus.
Farci P; Gerin JL; Aragona M; Lindsey I; Crivelli O; Balestrieri A; Smedile A; Thomas HC; Rizzetto M
JAMA; 1986 Mar; 255(11):1443-6. PubMed ID: 3951078
[TBL] [Abstract][Full Text] [Related]
16. [Clinical significance of anti-HBc and IgM.anti-HBc].
Chen BJ
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1988 Apr; 10(2):104-9. PubMed ID: 2970316
[No Abstract] [Full Text] [Related]
17. Research on a new hepatitis B antigen-antibody system: e-anti-e.
Ortona L; Pizzigallo E; Federico G; Camilli G; Scian J
Boll Ist Sieroter Milan; 1977 Nov; 56(5):467-75. PubMed ID: 597398
[No Abstract] [Full Text] [Related]
18. [Correlation between circulating HBV-DNA, HBcAb titers and post-transfusional hepatitis B].
Bedarida G; Cambiè G; D'Agostino F
Riv Emoter Immunoematol; 1984; 31(1):88-100. PubMed ID: 6531624
[No Abstract] [Full Text] [Related]
19. [Clinical aspects of severe forms of serum hepatitis type B].
Ketiladze ES; Farber NA; Zhilina NN; Vorozhbieva TE; Savitskiĭ GI
Klin Med (Mosk); 1980 Jan; 58(1):46-52. PubMed ID: 6966013
[No Abstract] [Full Text] [Related]
20. IgM-anti-HBc as a marker of persistent and IgG-anti-HBc as a marker of past hepatitis B infection. A longitudinal study over 5 years.
Niermeiier P; Gips CH; Huizenga JR; Ringers J; Verkerk S; Houthuff HJ; Houwen B; Snijder JA; Nielsen JO
Acta Hepatogastroenterol (Stuttg); 1978 Oct; 25(5):360-4. PubMed ID: 726802
[No Abstract] [Full Text] [Related]
[Next] [New Search]
